Generation Bio Co(NASDAQ:GBIO) 
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous sy...
Website: http://www.generationbio.com
Founded: 2016
CEO: Cameron Geoffrey McDonough
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.90
H 4.00
L 3.60
C 3.70
V 820,812
10EMA 3.70
20EMA 3.70
60EMA 3.70
120EMA 3.70
250EMA 3.70